300. IgG4関連疾患 IgG4-related disease Clinical trials / Disease details
臨床試験数 : 40 / 薬物数 : 47 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000028918 | 2020-01-01 | 2020-01-07 | A randomized, double-blind controlled study of glucocorticoids combination with thalidomide in the treatment of IgG4-related diseases | Efficacy and safety of thalidomide in IgG4-related diseases | IgG4 related disease | control group:prednison combined with placebo;experimental group:prednison combined with thalidomide; | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | NULL | Recruiting | 18 | 80 | Both | control group:51;experimental group:51; | Phase 4 | China |